These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25723987)

  • 41. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization Models for HIV/AIDS Resource Allocation: A Systematic Review.
    Avanceña ALV; Hutton DW
    Value Health; 2020 Nov; 23(11):1509-1521. PubMed ID: 33127022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
    Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
    AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
    Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission.
    Nagelkerke NJ; Jha P; de Vlas SJ; Korenromp EL; Moses S; Blanchard JF; Plummer FA
    Bull World Health Organ; 2002; 80(2):89-96. PubMed ID: 11953786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
    Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
    Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India.
    Vassall A; Pickles M; Chandrashekar S; Boily MC; Shetty G; Guinness L; Lowndes CM; Bradley J; Moses S; Alary M; ; Vickerman P
    Lancet Glob Health; 2014 Sep; 2(9):e531-e540. PubMed ID: 25304420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users.
    Richter A; Brandeau ML; Owens DK
    Med Decis Making; 1999; 19(2):167-79. PubMed ID: 10231079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changing Dynamics of HIV Transmission in Côte d'Ivoire: Modeling Who Acquired and Transmitted Infections and Estimating the Impact of Past HIV Interventions (1976-2015).
    Maheu-Giroux M; Vesga JF; Diabaté S; Alary M; Baral S; Diouf D; Abo K; Boily MC
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):517-527. PubMed ID: 28471837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Data and methods to characterize the role of sex work and to inform sex work programs in generalized HIV epidemics: evidence to challenge assumptions.
    Mishra S; Boily MC; Schwartz S; Beyrer C; Blanchard JF; Moses S; Castor D; Phaswana-Mafuya N; Vickerman P; Drame F; Alary M; Baral SD
    Ann Epidemiol; 2016 Aug; 26(8):557-569. PubMed ID: 27421700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reconceptualizing the HIV epidemiology and prevention needs of Female Sex Workers (FSW) in Swaziland.
    Baral S; Ketende S; Green JL; Chen PA; Grosso A; Sithole B; Ntshangase C; Yam E; Kerrigan D; Kennedy CE; Adams D
    PLoS One; 2014; 9(12):e115465. PubMed ID: 25531771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic.
    Sweat M; Kerrigan D; Moreno L; Rosario S; Gomez B; Jerez H; Weiss E; Barrington C
    J Health Commun; 2006; 11 Suppl 2():123-42. PubMed ID: 17148102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigating Voluntary Medical Male Circumcision Program Efficiency Gains through Subpopulation Prioritization: Insights from Application to Zambia.
    Awad SF; Sgaier SK; Tambatamba BC; Mohamoud YA; Lau FK; Reed JB; Njeuhmeli E; Abu-Raddad LJ
    PLoS One; 2015; 10(12):e0145729. PubMed ID: 26716442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention.
    Hunter DJ
    Epidemiology; 1993 Jan; 4(1):63-72. PubMed ID: 8420583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.
    Li J; Peng L; Gilmour S; Gu J; Ruan Y; Zou H; Hao C; Hao Y; Lau JT
    BMC Infect Dis; 2018 Nov; 18(1):600. PubMed ID: 30486800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis.
    Haacker M; Fraser-Hurt N; Gorgens M
    PLoS Med; 2016 May; 13(5):e1002012. PubMed ID: 27138961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimal investment in HIV prevention programs: more is not always better.
    Brandeau ML; Zaric GS
    Health Care Manag Sci; 2009 Mar; 12(1):27-37. PubMed ID: 19938440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A social systems analysis of implementation of El Salvador's national HIV combination prevention: a research agenda for evaluating Global Health Initiatives.
    Dickson-Gomez J; Glasman LA; Bodnar G; Murphy M
    BMC Health Serv Res; 2018 Nov; 18(1):848. PubMed ID: 30419904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.